Basics Senseonics Holdings, Inc. Senseonics Holdings Inc is a medical technology company engaged in designing, development and commercialization of glucose monitoring systems for diabetes patients. IPO Date: February 22, 2000 Sector: Healthcare Industry: Medical Diagnostics and Research Market Cap: $270.48M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.90% Avg Daily Range (30 D): $0.22 | 3.53% Avg Daily Range (90 D): $0.15 | 3.90% Institutional Daily Volume Avg Daily Volume: 5.28M Avg Daily Volume (30 D): .42M Avg Daily Volume (90 D): 4.37M Trade Size Avg Trade Size (Sh.): 446 Avg Trade Size (Sh.) (30 D): 102 Avg Trade Size (Sh.) (90 D): 608 Institutional Trades Total Inst.Trades: 440 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $1.95M Avg Inst. Trade (90 D): $1.95M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.41M Avg Closing Trade (30 D): $3.15M Avg Closing Trade (90 D): $3.15M Avg Closing Volume: 79.52K     News Oct 7, 2025 @ 5:17 PM Senseonics Tumbles As Q3 Results And Split Hit Sto... Source: Lekha Gupta May 21, 2025 @ 9:06 PM Senseonics Holdings, Inc. Announces Closing of Pub... Source: N/A May 21, 2025 @ 5:47 PM Diabetic Care Device Market Set for Significant Gr... Source: Bcc Research Jan 8, 2025 @ 11:12 PM Senseonics Holdings, Inc. Announces Business Updat... Source: N/A Sep 17, 2024 @ 11:00 AM Eversense 365 Receives FDA Clearance: The Worldââ... Source: Senseonics Holdings, Inc. And Ascensia Diabetes Care Financials   TTM Q3 2025 Q2 2025 Basic EPS $.74 $-.43 $-.02 Diluted EPS $.74 $-.43 $-.02 Revenue $ 29.3M $ 8.1M $ 6.65M Gross Profit $ 12.05M $ 3.47M $ 3.12M Net Income / Loss $ -63.77M $ -19.53M $ -14.5M Operating Income / Loss $ -61.68M $ -19.6M $ -14.32M Cost of Revenue $ 17.25M $ 4.63M $ 3.53M Net Cash Flow $ 7.35M $ 2.94M $ -7.79M PE Ratio 8.95     Splits Oct 20, 2025:   1:20 Nov 10, 2015:   12:1